New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Akoya Biosciences, Inc.
AKYA
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

145M

Medical - Instruments & Supplies

Next Earning date - 03 Mar 2025

145M

Medical - Instruments & Supplies

Next Earning date - 03 Mar 2025

2.93USD
Shape-0.10 ( -3.30%)
favorite-chart

Relative Strenght

19
favorite-chart

Volume Buzz

89%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

54%

Quote Panel

Shape
Updated January 14, 2025
1W 10.15 % 1M 21.07 % 3M -6.39 % 1Y -34.01 %

Key Metrics

Shape
  • Market Cap

    145.22M


  • Shares Outstanding

    49.56M


  • Share in Float

    20.61M


  • Dividende

    0


  • Earning Date

    03 Mar 2025


  • Price Target

    2.93


  • Average Volume

    557140


  • Beta

    1.346


  • Range

    1.88-6.31


  • Industry

    Medical - Instruments & Supplies


  • Website

    https://www.akoyabio.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

AKYA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$92M

Shape387%

2025-Revenue

$0.62

Shape-196%

2025-EPS

$43M

Shape-617%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

4.00(36.52%)

Number of analyst

1

Last analyst upgrade/downgrade

Morgan Stanley

downgrade

Previous: Overweight

2024-08-06

Now: Equal-Weight

BTIG

downgrade

Previous: Buy

2024-08-06

Now: Neutral

Craig-Hallum

initialise

Previous: Not converted

2024-06-21

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.50
vs -0.47

Q1.23

arrow
arrow

N/A

-0.49
vs -0.44

Q2.23

arrow
arrow

N/A

-0.51
vs -0.47

Q3.23

arrow
arrow

N/A

-0.26
vs -0.47

Q4.23

arrow
arrow

N/A

-0.22
vs -0.50

Q1.24

arrow
arrow

N/A

-0.35
vs -0.49

Q2.24

arrow
arrow

N/A

-0.27
vs -0.51

Q3.24

arrow
arrow

N/A

-0.18
vs -0.26

Q4.24

arrow
arrow

N/A

-0.16
vs -0.22

Q1.25

arrow
arrow

N/A

-0.20
vs -0.35

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+31%

21.2M  vs 16.2M

Q1.23

arrow
arrow

+27%

21.4M  vs 16.9M

Q2.23

arrow
arrow

+31%

23.5M  vs 17.9M

Q3.23

arrow
arrow

+34%

25.2M  vs 18.9M

Q4.23

arrow
arrow

+25%

26.5M  vs 21.2M

Q1.24

arrow
arrow

-14%

18.4M  vs 21.4M

Q2.24

arrow
arrow

-2%

23.2M  vs 23.5M

Q3.24

arrow
arrow

-25%

18.8M  vs 25.2M

Q4.24

arrow
arrow

-19%

21.5M  vs 26.5M

Q1.25

arrow
arrow

+9%

20.1M  vs 18.4M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-32%

-0.32
vs -0.24

Q1.23

arrow
arrow

-45%

-0.45
vs -0.32

Q2.23

arrow
arrow

-29%

-0.29
vs -0.45

Q3.23

arrow
arrow

-21%

-0.21
vs -0.29

Q4.23

arrow
arrow

-20%

-0.20
vs -0.21

Q1.24

arrow
arrow

-72%

-0.72
vs -0.20

Q2.24

arrow
arrow

-59%

-0.59
vs -0.72

Q3.24

arrow
arrow

-77%

-0.77
vs -0.59

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

73

73
vs 61

20%

Q1.23

arrow
arrow

65

65
vs 73

-11%

Q2.23

arrow
arrow

77

77
vs 65

18%

Q3.23

arrow
arrow

64

64
vs 77

-17%

Q4.23

arrow
arrow

66

66
vs 64

3%

Q1.24

arrow
arrow

68

68
vs 66

3%

Q2.24

arrow
arrow

60

60
vs 68

-12%

Q3.24

arrow
arrow

60

60
vs 60

NA

Earnings Growth

Latest News